---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-138936"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T23:54:10.060007+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Teva appoints Matthew Shields as EVP Global Operations; Eric Drapé departs after 11 years

## Summary
- Matthew Shields becomes EVP Global Operations effective June 3, 2024, based in Parsippany, NJ.
- Shields previously SVP Manufacturing at Merck Animal Health; prior roles at Sanofi and Amgen.
- Initial base salary of $825,000 with 100% target annual cash incentive, equity awards, and $200,000 sign-on cash.
- Eric Drapé leaves Teva after 11 years, including over 4 years as EVP Global Operations.
- Shields reports directly to CEO Richard Francis as part of the Pivot to Growth strategy.

## SEC filing metadata
- accession: 0001193125-24-138936
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312524138936/0001193125-24-138936-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312524138936/d820660d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-138936
- JSON: https://secwatch.observer/filing/0001193125-24-138936.json
- Plain text: https://secwatch.observer/filing/0001193125-24-138936.txt

## Key facts
- Executive change
  Eric Drapé departed as Executive Vice President, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD.
  - Action: will be leaving
  - Role: Executive Vice President, Global Operations
  source text: Mr. Eric Drapé, Executive Vice President, Global Operations, will be leaving Teva Pharmaceutical Industries Ltd.
  evidence_url: https://www.sec.gov/Archives/edgar/data/818686/000119312524138936/0001193125-24-138936-index.htm
- Executive change
  Matthew Shields was appointed as Executive Vice President, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD.
  - Action: appointed
  - Role: Executive Vice President, Global Operations
  source text: Mr. Matthew Shields has been appointed as Executive Vice President, Global Operations of Teva and a member of Teva Executive Management, effective June 3, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/818686/000119312524138936/0001193125-24-138936-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.